{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:23:14Z","timestamp":1787008994559,"version":"build-2736575974"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2021,8,15]],"date-time":"2021-08-15T00:00:00Z","timestamp":1628985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Epidemiologic, clinical, molecular and translational research findings support an interrelationship between Chlamydia trachomatis, pelvic inflammatory disease (PID), and epithelial ovarian cancer (EOC). Overall, the link between C. trachomatis, PID, and EOC seems to be relatively weak, although nondifferential misclassification bias may have attenuated the results. The predominant tubal origin of EOC and the role of chronic inflammation in tumorigenesis suggest that the association is biologically plausible. Thus, C. trachomatis and PID may represent potential risk factors or risk markers for EOC. However, many steps in this chain of events are still poorly understood and need to be addressed in future studies. Research gaps include time of exposure in relation to the long-term consequences and lag time to EOC. Data of differential risk for EOC between chlamydial and nonchlamydial PID is also needed. Another major research gap has been the absence of high-performance biomarkers for C. trachomatis, PID, and EOC, as well as EOC precursors. Biomarkers for C. trachomatis and PID leading to increased risk of EOC should be developed. If the association is confirmed, C. trachomatis and PID prevention efforts may play a role in reducing the burden of EOC.<\/jats:p>","DOI":"10.1093\/infdis\/jiab017","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T17:45:47Z","timestamp":1610646347000},"page":"S121-S127","source":"Crossref","is-referenced-by-count":34,"title":["<i>Chlamydia trachomatis<\/i>\n                    , Pelvic Inflammatory Disease, and Epithelial Ovarian Cancer"],"prefix":"10.1093","volume":"224","author":[{"given":"Jorma","family":"Paavonen","sequence":"first","affiliation":[{"name":"Professor Emeritus, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Turzanski Fortner","sequence":"additional","affiliation":[{"name":"DKFZ, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Lehtinen","sequence":"additional","affiliation":[{"name":"Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Idahl","sequence":"additional","affiliation":[{"name":"Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"key":"2021081606011021800_CIT0001","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol Med"},{"key":"2021081606011021800_CIT0002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"2021081606011021800_CIT0003","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int J Womens Health"},{"key":"2021081606011021800_CIT0004","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/ijc.30676","article-title":"International patterns and trends in ovarian cancer incidence, overall and by histologic subtype","volume":"140","author":"Coburn","year":"2017","journal-title":"Int J Cancer"},{"key":"2021081606011021800_CIT0005","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMra1813254","article-title":"Mucinous ovarian carcinoma","volume":"380","author":"Morice","year":"2019","journal-title":"N Engl J Med"},{"key":"2021081606011021800_CIT0006","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"2021081606011021800_CIT0007","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"2021081606011021800_CIT0008","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am J Pathol"},{"key":"2021081606011021800_CIT0009","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41467-017-01217-9","article-title":"Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma","volume":"8","author":"Ducie","year":"2017","journal-title":"Nat Commun"},{"key":"2021081606011021800_CIT0010","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"key":"2021081606011021800_CIT0011","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","article-title":"Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"2021081606011021800_CIT0012","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1038\/s41467-019-11862-x","article-title":"The molecular origin and taxonomy of mucinous ovarian carcinoma","volume":"10","author":"Cheasley","year":"2019","journal-title":"Nat Commun"},{"key":"2021081606011021800_CIT0013","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J Clin Oncol"},{"key":"2021081606011021800_CIT0014","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41416-019-0422-9","article-title":"Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses\u2019 Health Studies","volume":"120","author":"Fortner","year":"2019","journal-title":"Br J Cancer"},{"key":"2021081606011021800_CIT0015","first-page":"1187","article-title":"Ovarian epithelial tumors and reproductive factors: a systematic review","volume":"287","author":"Schuler","year":"2018","journal-title":"Gynecol Obstet"},{"key":"2021081606011021800_CIT0016","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol Med"},{"key":"2021081606011021800_CIT0017","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1158\/1940-6207.CAPR-13-0037","article-title":"Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls","volume":"6","author":"Terry","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"key":"2021081606011021800_CIT0018","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.2019.20079","article-title":"Association of powder use in the genital area with risk of ovarian cancer","volume":"323","author":"O\u2019Brien","year":"2020","journal-title":"JAMA"},{"key":"2021081606011021800_CIT0019","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ygyno.2019.12.011","article-title":"Predictors of survival trajectories among women with epithelial ovarian cancer","volume":"156","author":"Peres","year":"2020","journal-title":"Gynecol Oncol"},{"key":"2021081606011021800_CIT0020","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"2021081606011021800_CIT0021","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/ijc.23173","article-title":"Inflammation and cancer: an ancient link with novel potentials","volume":"121","author":"Hussain","year":"2007","journal-title":"Int J Cancer"},{"key":"2021081606011021800_CIT0022","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3892\/ol.2017.6388","article-title":"Microbial infection, inflammation and epithelial ovarian cancer","volume":"14","author":"Xie","year":"2017","journal-title":"Oncol Lett"},{"key":"2021081606011021800_CIT0023","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/aje\/kww161","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 case-control studies","volume":"185","author":"Rasmussen","year":"2017","journal-title":"Am J Epidemiol"},{"key":"2021081606011021800_CIT0024","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10552-017-0873-3","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis","volume":"28","author":"Zhou","year":"2017","journal-title":"Cancer Causes Control"},{"key":"2021081606011021800_CIT0025","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.4161\/cc.8.19.9590","article-title":"Inflammation: a hidden path to breaking the spell of ovarian cancer","volume":"8","author":"Shan","year":"2009","journal-title":"Cell Cycle"},{"key":"2021081606011021800_CIT0026","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1158\/1055-9965.EPI-16-0120","article-title":"Inflammatory markers of CRP, IL6, TNF\u03b1, and soluble TNFR2 and the risk of ovarian cancer: a meta-analysis of prospective studies","volume":"25","author":"Zeng","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2021081606011021800_CIT0027","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/EDE.0b013e3182456ad3","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer","volume":"23","author":"Lo-Ciganic","year":"2012","journal-title":"Epidemiology"},{"key":"2021081606011021800_CIT0028","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djy084","article-title":"Antibodies against Chlamydia trachomatis and ovarian cancer risk in two independent populations","volume":"111","author":"Trabert","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"2021081606011021800_CIT0029","doi-asserted-by":"crossref","first-page":"djt431","DOI":"10.1093\/jnci\/djt431","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium","volume":"106","author":"Trabert","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2021081606011021800_CIT0030","doi-asserted-by":"crossref","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"key":"2021081606011021800_CIT0031","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri1551","article-title":"Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine","volume":"5","author":"Brunham","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"2021081606011021800_CIT0032","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/humupd\/5.5.433","article-title":"Chlamydia trachomatis: impact on human reproduction","volume":"5","author":"Paavonen","year":"1999","journal-title":"Hum Reprod Update"},{"key":"2021081606011021800_CIT0033","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/07853890.2010.546365","article-title":"Chlamydia trachomatis infections of the female genital tract: State of the art","volume":"44","author":"Paavonen","year":"2012","journal-title":"Ann Med"},{"key":"2021081606011021800_CIT0034","first-page":"183","article-title":"Immunopathogenesis of chlamydial infections","volume":"412","author":"Murthy","year":"2018","journal-title":"Curr Top Microbiol Immunol"},{"key":"2021081606011021800_CIT0035","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/OLQ.0000000000000028","article-title":"Pelvic inflammatory disease: identifying research gaps\u2014proceedings of a workshop sponsored by Department of Health and Human Services\/National Institutes of Health\/National Institute of Allergy and Infectious Diseases, November 3-4, 2011","volume":"40","author":"Darville","year":"2013","journal-title":"Sex Transm Dis"},{"key":"2021081606011021800_CIT0036","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jama.1990.03440010052029","article-title":"Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use","volume":"263","author":"W\u00f6lner-Hanssen","year":"1990","journal-title":"JAMA"},{"key":"2021081606011021800_CIT0037","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.1016\/S1473-3099(18)30159-2","article-title":"Advancing the public health applications of Chlamydia trachomatis serology","volume":"18","author":"Woodhall","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2021081606011021800_CIT0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198407053110101","article-title":"Mucopurulent cervicitis\u2014the ignored counterpart in women of urethritis in men","volume":"311","author":"Brunham","year":"1984","journal-title":"N Engl J Med"},{"key":"2021081606011021800_CIT0039","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/jcp.38.7.726","article-title":"Chlamydial endometritis","volume":"38","author":"Paavonen","year":"1985","journal-title":"J Clin Pathol"},{"key":"2021081606011021800_CIT0040","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0002-9378(85)80210-6","article-title":"Prevalence and manifestations of endometritis among women with cervicitis","volume":"152","author":"Paavonen","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"2021081606011021800_CIT0041","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra1411426","article-title":"Pelvic inflammatory disease","volume":"372","author":"Brunham","year":"2015","journal-title":"N Engl J Med"},{"key":"2021081606011021800_CIT0042","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/OLQ.0000000000001221","article-title":"Clearance of Mycoplasma genitalium and Trichomonas vaginalis among adolescents and young adults with pelvic inflammatory disease: Results from the Tech-N study","volume":"47","author":"Trent","year":"2020","journal-title":"Sex Transm Dis"},{"key":"2021081606011021800_CIT0043","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/humrep\/des136","article-title":"Effect of IL12A and IL12B polymorphisms on the risk of Chlamydia trachomatis-induced tubal factor infertility and disease severity","volume":"27","author":"\u00d6hman","year":"2012","journal-title":"Hum Reprod"},{"key":"2021081606011021800_CIT0044","first-page":"S32","article-title":"Sexually transmitted diseases and infertility","volume":"21","author":"Westr\u00f6m","year":"1994","journal-title":"Sex Transm Dis"},{"key":"2021081606011021800_CIT0045","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/ije\/dyh029","article-title":"Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes\u2013implications for cost-effectiveness analyses","volume":"33","author":"van Valkengoed","year":"2004","journal-title":"Int J Epidemiol"},{"key":"2021081606011021800_CIT0046"},{"key":"2021081606011021800_CIT0047","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"2021081606011021800_CIT0048","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1148\/radiology.210.1.r99ja04209","article-title":"MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US","volume":"210","author":"Tukeva","year":"1999","journal-title":"Radiology"},{"key":"2021081606011021800_CIT0049","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1469-0705.2001.00353.x","article-title":"Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease","volume":"17","author":"Molander","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2021081606011021800_CIT0050","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00404-013-3091-6","article-title":"The sensitivity and specificity of transvaginal ultrasound with regard to acute pelvic inflammatory disease: a review of the literature","volume":"289","author":"Romosan","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"2021081606011021800_CIT0051","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/CVI.00021-09","article-title":"Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection","volume":"16","author":"Wills","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"2021081606011021800_CIT0052","doi-asserted-by":"crossref","first-page":"e0208652","DOI":"10.1371\/journal.pone.0208652","article-title":"Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infections","volume":"13","author":"Blomquist","year":"2018","journal-title":"PLoS One"},{"key":"2021081606011021800_CIT0053","first-page":"391","article-title":"Predictive values of serum Chlamydia trachomatis TroA and HtrA IgG antibodies as markers of persistent infection in the detection of pelvic adhesions and tubal occlusion","volume-title":"Microorganisms","author":"Rantsi","year":"2019"},{"key":"2021081606011021800_CIT0054","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10096-016-2769-7","article-title":"Antibody to Chlamydia trachomatis proteins, TroA and HtrA, as a biomarker for Chlamydia trachomatis infection","volume":"36","author":"Hokynar","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021081606011021800_CIT0055","doi-asserted-by":"crossref","first-page":"71.e1","DOI":"10.1016\/j.ajog.2009.07.042","article-title":"Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions","volume":"202","author":"Idahl","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"2021081606011021800_CIT0056","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tranon.2018.02.008","article-title":"Chlamydia trachomatis, chlamydial heat shock protein 60 and anti-chlamydial antibodies in women with epithelial ovarian tumors","volume":"11","author":"Jonsson","year":"2018","journal-title":"Transl Oncol"},{"key":"2021081606011021800_CIT0057","doi-asserted-by":"crossref","first-page":"824627","DOI":"10.1155\/2011\/824627","article-title":"Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors","volume":"2011","author":"Idahl","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"2021081606011021800_CIT0058","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/ijc.32999","article-title":"Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: results from the EPIC cohort","volume":"147","author":"Idahl","year":"2020","journal-title":"Int J Cancer"},{"key":"2021081606011021800_CIT0059","first-page":"447","article-title":"Pelvic inflammatory disease and the risk of epithelial ovarian cancer","volume":"4","author":"Risch","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2021081606011021800_CIT0060","first-page":"667","article-title":"Pelvic inflammatory disease and risk of ovarian cancer","volume":"5","author":"Parazzini","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2021081606011021800_CIT0061","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10552-013-0216-y","article-title":"Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors","volume":"24","author":"Rasmussen","year":"2013","journal-title":"Cancer Causes Control"},{"key":"2021081606011021800_CIT0062","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1086\/368380","article-title":"Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer","volume":"187","author":"Ness","year":"2003","journal-title":"J Infect Dis"},{"key":"2021081606011021800_CIT0063","doi-asserted-by":"crossref","first-page":"219672","DOI":"10.1155\/2008\/219672","article-title":"Chlamydia trachomatis serology in women with and without ovarian cancer","volume":"2008","author":"Ness","year":"2008","journal-title":"Infect Dis Obstet Gynecol"},{"key":"2021081606011021800_CIT0064","first-page":"117","article-title":"Could epithelial ovarian cancer be associated with chlamydial infection?","volume":"28","author":"Wong","year":"2007","journal-title":"Eur J Gynaecol Oncol"},{"key":"2021081606011021800_CIT0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/1055-9965.EPI-16-0459","article-title":"Is pelvic inflammatory disease a risk factor for ovarian cancer?","volume":"26","author":"Rasmussen","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2021081606011021800_CIT0066","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","article-title":"Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study","volume":"12","author":"Lin","year":"2011","journal-title":"Lancet Oncol"},{"key":"2021081606011021800_CIT0067","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107:dju410","author":"Falconer","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"2021081606011021800_CIT0068","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aogs.12516","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2021081606011021800_CIT0069","doi-asserted-by":"crossref","first-page":"e12986","DOI":"10.1111\/cmi.12986","article-title":"Chlamydia trachomatis impairs host base excision repair by downregulating polymerase \u03b2","volume":"21","author":"Gulve","year":"2019","journal-title":"Cell Microbiol"},{"key":"2021081606011021800_CIT0070","doi-asserted-by":"crossref","first-page":"e01465-18","DOI":"10.1128\/mBio.01465-18","article-title":"Chlamydia trachomatis inhibits homologous recombination repair of DNA breaks by interfering with PP2A signaling","volume":"9","author":"Mi","year":"2018","journal-title":"mBio"},{"key":"2021081606011021800_CIT0071","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.chom.2013.05.010","article-title":"Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response","volume":"13","author":"Chumduri","year":"2013","journal-title":"Cell Host Microbe"},{"key":"2021081606011021800_CIT0072","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.187.4.487","article-title":"Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation","volume":"187","author":"Fan","year":"1998","journal-title":"J Exp Med"},{"key":"2021081606011021800_CIT0073","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.celrep.2019.01.006","article-title":"Integrated phosphoproteome and transcriptome analysis reveals Chlamydia-induced epithelial-to-mesenchymal transition in host cells","volume":"26","author":"Zadora","year":"2019","journal-title":"Cell Rep"},{"key":"2021081606011021800_CIT0074","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/s41467-019-09144-7","article-title":"Chronic Chlamydia infection in human organoids increases stemness and promotes age-dependent CpG methylation","volume":"10","author":"Kessler","year":"2019","journal-title":"Nat Commun"},{"key":"2021081606011021800_CIT0075","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_2\/S121\/39734902\/jiab017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_2\/S121\/39734902\/jiab017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T02:03:19Z","timestamp":1629079399000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/224\/Supplement_2\/S121\/6352166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,15]]},"references-count":75,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2021,8,16]]},"published-print":{"date-parts":[[2021,8,16]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiab017","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,15]]},"published":{"date-parts":[[2021,8,15]]}}}